Total Payments
$16,023
2024 Payments
$2,321
Companies
50
Transactions
656
Medicare Patients
4,426
Medicare Billing
$491,730
Payment Breakdown by Category
Food & Beverage$13,020 (81.3%)
Travel$2,580 (16.1%)
Education$423.22 (2.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,020 | 637 | 81.3% |
| Travel and Lodging | $2,580 | 10 | 16.1% |
| Education | $423.22 | 9 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,972 | 93 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,802 | 111 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,715 | 86 | $0 (2024) |
| Olympus Corporation of the Americas | $1,285 | 11 | $0 (2018) |
| Pulmonx Corporation | $1,108 | 3 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $776.86 | 28 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $680.03 | 21 | $0 (2024) |
| GENZYME CORPORATION | $592.33 | 29 | $0 (2024) |
| United Therapeutics Corporation | $553.97 | 21 | $0 (2024) |
| Noah Medical Corporation | $416.97 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,321 | 74 | Noah Medical Corporation ($416.97) |
| 2023 | $2,037 | 90 | AstraZeneca Pharmaceuticals LP ($340.38) |
| 2022 | $1,799 | 80 | AstraZeneca Pharmaceuticals LP ($381.94) |
| 2021 | $1,943 | 89 | AstraZeneca Pharmaceuticals LP ($476.76) |
| 2020 | $950.49 | 54 | Boehringer Ingelheim Pharmaceuticals, Inc. ($155.17) |
| 2019 | $2,340 | 70 | Pulmonx Corporation ($1,108) |
| 2018 | $3,064 | 108 | Olympus Corporation of the Americas ($1,285) |
| 2017 | $1,568 | 91 | Boehringer Ingelheim Pharmaceuticals, Inc. ($342.99) |
All Payment Transactions
656 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| Category: HFCWO | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: Airway Clearance Device | ||||||
| 12/05/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $34.33 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: Immunology | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/07/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Noah Medical Corporation | GALAXY (Device) | Travel and Lodging | Cash or cash equivalent | $416.97 | General |
| Category: Bronchoscope (Flexible Or Rigid) And Accessories | ||||||
| 10/29/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $37.77 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: CRITICAL CARE | ||||||
| 10/23/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: Immunology | ||||||
| 09/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/24/2024 | Boston Scientific Corporation | EkoSonic (Device) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: EkoSonic_PI | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,046 | 1,282 | $289,593 | $97,301 |
| 2022 | 25 | 1,253 | 1,643 | $406,793 | $153,865 |
| 2021 | 27 | 1,219 | 1,497 | $393,539 | $139,210 |
| 2020 | 22 | 908 | 1,153 | $302,301 | $101,353 |
Total Patients
4,426
Total Services
5,575
Medicare Billing
$491,730
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 131 | 220 | $52,713 | $21,872 | 41.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 59 | 103 | $44,319 | $17,682 | 39.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 100 | 100 | $35,000 | $14,323 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 158 | $40,942 | $13,841 | 33.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 114 | 175 | $27,859 | $11,820 | 42.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 34 | $8,858 | $3,755 | 42.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 19 | $6,928 | $2,730 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 43 | $7,878 | $2,660 | 33.8% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 16 | 16 | $3,768 | $1,408 | 37.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $4,050 | $1,253 | 30.9% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 14 | 14 | $6,143 | $936.46 | 15.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 19 | 22 | $2,187 | $876.95 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 12 | $3,102 | $777.50 | 25.1% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 12 | 12 | $15,569 | $776.88 | 5.0% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 98 | 99 | $10,969 | $692.64 | 6.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 99 | 100 | $11,565 | $518.74 | 4.5% |
| 94375 | Test to measure rate of airflow | Facility | 2023 | 54 | 55 | $4,282 | $487.19 | 11.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $743.28 | $373.20 | 50.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 34 | 34 | $689.26 | $194.16 | 28.2% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 14 | 14 | $493.48 | $180.96 | 36.7% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 28 | 28 | $1,536 | $142.56 | 9.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 209 | 382 | $79,784 | $34,598 | 43.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 179 | 183 | $73,993 | $30,825 | 41.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 105 | 164 | $73,165 | $28,354 | 38.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 192 | 301 | $43,760 | $19,475 | 44.5% |
About Dr. Robert Chasse, MD
Dr. Robert Chasse, MD is a Pulmonary Disease healthcare provider based in Salisbury, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619967049.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Chasse, MD has received a total of $16,023 in payments from pharmaceutical and medical device companies, with $2,321 received in 2024. These payments were reported across 656 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($13,020).
As a Medicare-enrolled provider, Chasse has provided services to 4,426 Medicare beneficiaries, totaling 5,575 services with total Medicare billing of $491,730. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Salisbury, MD
- Active Since 10/26/2005
- Last Updated 04/22/2014
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1619967049
Products in Payments
- Olympus EBUS Bronchoscopes (Device) $1,285
- Pulmonx Endobronchial Valve EBV (Device) $1,108
- DUPIXENT (Biological) $975.45
- ACTHAR (Biological) $849.88
- NUCALA (Biological) $836.07
- OFEV (Drug) $834.11
- BREZTRI (Drug) $596.53
- FASENRA (Biological) $519.57
- TRELEGY ELLIPTA (Drug) $490.58
- TEZSPIRE (Biological) $461.37
- GLASSIA (Biological) $458.83
- GALAXY (Device) $416.97
- STIOLTO RESPIMAT (Drug) $391.59
- UPTRAVI (Drug) $363.07
- OPSUMIT (Drug) $335.02
- SYMBICORT (Drug) $329.05
- ORENITRAM (Drug) $285.30
- ANORO (Drug) $265.08
- Xolair (Biological) $232.18
- Arikayce (Drug) $217.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Salisbury
Tania Hudson, Md, MD
Pulmonary Disease — Payments: $11,086
Pulmonary Disease $11,086
Dr. Yashvir Sangwan, M.d, M.D
Pulmonary Disease — Payments: $10,744
Pulmonary Disease $10,744
George Reeder, Md, MD
Pulmonary Disease — Payments: $2,634
Pulmonary Disease $2,634
Hafiza Noor Ul Ain Baloch, Md, MD
Pulmonary Disease — Payments: $1,898
Pulmonary Disease $1,898
Gregory Thompson, Md, MD
Pulmonary Disease — Payments: $269.67
Pulmonary Disease $269.67
Stephen Proctor, Md, MD
Pulmonary Disease — Payments: $106.07
Pulmonary Disease $106.07